Summary
Overview
Work History
Education
Affiliations
Certification
Current Position
Clinical training
CLINICAL RESEARCH
Publications
Abstracts
Lectures presentations
Extracurricular Activities
Hobbies and Interests
Projects
Contactinformation
Personal Information
Timeline
Generic

Hashem A Younes, MD

Abu Dhabi

Summary

A hematologist/ Oncologist with more than 20 years' experience. Demonstrated ability to improve patient outcomes through comprehensive treatment plans and effective communication with multidisciplinary teams. Proven track record of utilizing critical thinking and diagnostic skills to deliver high-quality healthcare. With a master degree in clinical research methods and analysis, I led and participated in multiple oncology clinical trials aimed at improving outcomes of patients.

Overview

25
25
years of professional experience
1
1
Certification

Work History

Consultant Hematologist/Oncologist

Cleveland Clinic Abu Dhabi
09.2025 - Current

Hematologist/ Oncologist

Allegheny Health Network
01.2009 - 09.2025

Fellow, Hematology/Oncology

University of Pittsburgh Medical Center
01.2006 - 01.2009

Resident, Internal Medicine

University of Pittsburgh Medical Center
01.2004 - 01.2006

Intern, Internal Medicine

University of Pittsburgh Medical Center
01.2003 - 01.2004

Intern, Internal Medicine

American University of Beirut
01.2001 - 01.2002

Education

Clinical Research Training Program - Clinical Research

University of Pittsburgh
Pittsburgh, PA
01.2005

M.D. -

American University of Beirut
Beirut, Lebanon
07.2001

Bachelor of Science - Biology

American University of Beirut
Beirut, Lebanon
07.1996

Affiliations

  • American Society of Clinical Oncology (ASCO)
  • American Society of Hematology (ASH)
  • Society for Immunotherapy of Cancer (SITC)

Certification

  • ECFMG certification, 01/01/02, # 0-609-700-0
  • American Board of Internal Medicine, 01/01/06
  • Hematology, 01/01/10
  • Medical Oncology, 01/01/11

Current Position

Hematologist/ Oncologist, Allegheny Health Network, Pittsburgh, PA, 04/01/09 to present

Melanoma/ Skin Cancers Institute Medical Leader, Allegheny Health Network, Pittsburgh, PA, 06/01/2020 to present

Hematology/ Oncology staff physician, University of Pittsburgh Medical Center, Shadyside and East hospitals, 04/01/2009 to present

Clinical training

  • Internship, Internal Medicine, American University of Beirut, University of Pittsburgh, American University Hospital, 01/01/01, 12/31/02
  • Internship, Internal Medicine, University of Pittsburgh Medical Center, 01/01/03, 12/31/04
  • Residency, Internal Medicine, University of Pittsburgh Medical Center, 01/01/04, 12/31/06
  • Fellowship, Hematology/Oncology, University of Pittsburgh Medical Center, 01/01/06, 12/31/09

CLINICAL RESEARCH

  • Site PI, Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer
  • Site PI, Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134

Publications

  • Efficacy and Tolerability of Cyclical Intravenous Pamidronate in Patients with Low Bone Mass, J Clin Densitometry, 05/01/02
  • The role of the PI3Kinase pathway in Multiple Myeloma (review), Clinical Cancer Research, 07/01/07
  • Targeting minor histocompatibility antigens in graft versus tumor or graft versus leukemia responses, Trends Immunol., 10/24/08
  • White RJ, Abel S, Horne ZD, Lee J, Edington H, Greenberg L, Younes H, Hilton C, Wegner RE. Melanoma brain metastases: is it time to eliminate radiotherapy? J Neurooncol. 2020 Aug;149(1):27-33. doi: 10.1007/s11060-020-03485-w. Epub 2020 Jun 15. PMID: 32556863.

Abstracts

  • A case of Amnesia Responsive to Phlebotomy, Society of General Internal Medicine (SGIM) annual meeting, Chicago, IL, 05/01/04
  • When b2 Agonists are Contraindicated in an Asthmatic Attack, Society of General Internal Medicine (SGIM) annual meeting, New Orleans, LA, 05/01/05
  • Not All Hemoptysis is TB, Society of General Internal Medicine (SGIM) regional meeting, New York, NY, 02/01/05
  • Identification of Allelic Variants of Low Molecular Weight Proteins in Mantle Cell Lymphoma as Potential Minor Histocompatibility Antigen Targets, Federation of Clinical Immunology Societies (FOCIS) annual meeting, Boston, MA, 06/01/08

Lectures presentations

  • Diagnosis and Treatment of Heparin Induced Thrombocytopenia, Internal Medicine Grand Round, 01/01/06
  • Non-Hodgkin's Lymphoma: Two Unusual Cases, Tumor board Conference, 01/01/07
  • A Case of Metastatic Carcinoma of Unknown Origin: Workup and Management, Tumor Board Conference, 01/01/08
  • Recombinant Humanized Monoclonal Antibody (Eculizumab) for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH), Fellow's Journal Club, 01/01/08
  • Bevacizumab plus Irinotecan for the Treatment of Glioblastoma Multiforme (GBM), Fellow's Journal Club, 01/01/08
  • Metastatic Carcinoma of Unknown Origin: Diagnosis, Workup, and Management, Medical Residents' Lecture Series, 01/01/08
  • Thromboprophylaxis in Cancer Patients with a Central Catheter, Fellow's Journal Club, 01/01/08
  • Diagnosis and Treatment of Multiple Myeloma, Medical Residents' Lecture Series, 01/01/08
  • Adjuvant Taxanes in Breast Cancer, Fellow's Journal Club, 01/01/08
  • Bone Marrow Transplantation in Hematologic Malignancies, Medical Residents' Lecture Series, 01/01/08
  • Acute and Chronic Leukemias, Physician Assistants and Nurse Practitioners' Education Series, 01/01/08
  • Minor Histocompatibility Complexes in Bone Marrow Transplantation, A Special Lecture, Rosewall Park Cancer Center, Buffalo, NY, 01/01/08
  • Skin Cancer Diagnosis and Management, Advanced Oncology Course at Allegheny Health Network, 2018 to present

Extracurricular Activities

President, Social Committee on Medical Education, Lebanese Medical Students Society, 01/01/00 Member, American University of Beirut Art Club, 01/01/00

Hobbies and Interests

Painting

Projects

Health Awareness in Beirut City, 01/01/98 Cancer Registry in Lebanon, 01/01/01 Role of PKR in pathogenesis of Multiple Myeloma, 01/01/02 Histone Deacetylase Inhibitor PXD 101 for the Treatment of Refractory/ Relapsed Multiple Myeloma, 01/01/08 CC-4047 Blocks the Osteoclast Formation By Inducing an Early Shift in Lineage Commitment, 01/01/08 Identification and characterization of minor histocompatibility antigens as a target for Graft-versus-Leukemia (GVL) effect, 01/01/08

Contactinformation

Work: 4800 Liberty Avenue, Suite 340, Pittsburgh, PA, 15224, 412-681-4401, 412-688-7555, hashem.younes@ahn.org,

Home: 58 Long Meadow Dr., Pittsburgh, PA, 15238, 412-519-5269

Personal Information

  • Citizenship: Lebanese, American.
  • Place of Birth: Beirut, Lebanon
  • Date of Birth: 07/05/1974

Timeline

Consultant Hematologist/Oncologist

Cleveland Clinic Abu Dhabi
09.2025 - Current

Hematologist/ Oncologist

Allegheny Health Network
01.2009 - 09.2025

Fellow, Hematology/Oncology

University of Pittsburgh Medical Center
01.2006 - 01.2009

Resident, Internal Medicine

University of Pittsburgh Medical Center
01.2004 - 01.2006

Intern, Internal Medicine

University of Pittsburgh Medical Center
01.2003 - 01.2004

Intern, Internal Medicine

American University of Beirut
01.2001 - 01.2002

M.D. -

American University of Beirut

Bachelor of Science - Biology

American University of Beirut

Clinical Research Training Program - Clinical Research

University of Pittsburgh
Hashem A Younes, MD